Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8662 | 1231 | 39.4 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
512 | 3 | BRCA1//BRCA2//FANCONI ANEMIA | 21435 |
1039 | 2 | GENETIC TESTING//BIOBANK//JOURNAL OF GENETIC COUNSELING | 10134 |
8662 | 1 | PHARMACOGENOMICS//HLA B5701//PERSONALIZED MEDICINE | 1231 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PHARMACOGENOMICS | authKW | 914625 | 23% | 13% | 280 |
2 | HLA B5701 | authKW | 765361 | 3% | 86% | 36 |
3 | PERSONALIZED MEDICINE | journal | 532627 | 9% | 20% | 108 |
4 | ABACAVIR | authKW | 394224 | 5% | 24% | 66 |
5 | PHARMACOGENETICS | authKW | 355989 | 20% | 6% | 246 |
6 | ABACAVIR HYPERSENSITIVITY | authKW | 303842 | 1% | 88% | 14 |
7 | COMPANION DIAGNOSTICS | authKW | 281967 | 3% | 30% | 38 |
8 | PHARMACOGENETIC TESTING | authKW | 240075 | 2% | 44% | 22 |
9 | PROGRAM PERSONALIZED MED TARGETED THER EUT | address | 145896 | 1% | 59% | 10 |
10 | PHARMACOGENOMICS EDUCATION | authKW | 124019 | 0% | 100% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 9638 | 52% | 0% | 634 |
2 | Genetics & Heredity | 1319 | 15% | 0% | 181 |
3 | Health Care Sciences & Services | 950 | 6% | 0% | 78 |
4 | Medical Ethics | 667 | 1% | 0% | 18 |
5 | Medical Informatics | 523 | 3% | 0% | 33 |
6 | Health Policy & Services | 433 | 3% | 0% | 41 |
7 | Social Sciences, Biomedical | 203 | 2% | 0% | 23 |
8 | Infectious Diseases | 199 | 5% | 0% | 56 |
9 | Biotechnology & Applied Microbiology | 186 | 7% | 0% | 82 |
10 | Ethics | 180 | 1% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROGRAM PERSONALIZED MED TARGETED THER EUT | 145896 | 1% | 59% | 10 |
2 | CLIN PHARMACOGEN CLIN SPECIMEN MANAGEMENT | 74411 | 0% | 100% | 3 |
3 | PERSONALIZED MED PROGRAM | 56367 | 0% | 45% | 5 |
4 | PHARM NAT HLTH SCI | 55807 | 0% | 75% | 3 |
5 | PHARMACOGEN PROGRAM | 55807 | 0% | 75% | 3 |
6 | CLIN PHARMACOGENOM CLIN SPECIMEN MANAGEMENT | 49607 | 0% | 100% | 2 |
7 | COMMUNITY PHARM IDENCY PROGRAM PGY1 | 49607 | 0% | 100% | 2 |
8 | MT SINAI PRACTICE ASSOCIATES PRIMARY CARE PRO | 49607 | 0% | 100% | 2 |
9 | PIPELINE PORTFOLIO PLANNING | 49607 | 0% | 100% | 2 |
10 | BIOINFORMAT HIGH THROUGHPUT DATA ANAL | 33070 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PERSONALIZED MEDICINE | 532627 | 9% | 20% | 108 |
2 | PHARMACOGENOMICS | 278498 | 11% | 8% | 141 |
3 | PUBLIC HEALTH GENOMICS | 42859 | 2% | 7% | 24 |
4 | PHARMACOGENOMICS JOURNAL | 24593 | 2% | 4% | 28 |
5 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 15277 | 5% | 1% | 60 |
6 | NATURE REVIEWS DRUG DISCOVERY | 10561 | 2% | 2% | 20 |
7 | GENETICS IN MEDICINE | 5524 | 2% | 1% | 19 |
8 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 5458 | 1% | 1% | 15 |
9 | ETHIK IN DER MEDIZIN | 4895 | 0% | 3% | 6 |
10 | PHARMACOGENETICS AND GENOMICS | 3674 | 1% | 1% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHARMACOGENOMICS | 914625 | 23% | 13% | 280 | Search PHARMACOGENOMICS | Search PHARMACOGENOMICS |
2 | HLA B5701 | 765361 | 3% | 86% | 36 | Search HLA+B5701 | Search HLA+B5701 |
3 | ABACAVIR | 394224 | 5% | 24% | 66 | Search ABACAVIR | Search ABACAVIR |
4 | PERSONALIZED MEDICINE | 393888 | 15% | 9% | 179 | Search PERSONALIZED+MEDICINE | Search PERSONALIZED+MEDICINE |
5 | PHARMACOGENETICS | 355989 | 20% | 6% | 246 | Search PHARMACOGENETICS | Search PHARMACOGENETICS |
6 | ABACAVIR HYPERSENSITIVITY | 303842 | 1% | 88% | 14 | Search ABACAVIR+HYPERSENSITIVITY | Search ABACAVIR+HYPERSENSITIVITY |
7 | COMPANION DIAGNOSTICS | 281967 | 3% | 30% | 38 | Search COMPANION+DIAGNOSTICS | Search COMPANION+DIAGNOSTICS |
8 | PHARMACOGENETIC TESTING | 240075 | 2% | 44% | 22 | Search PHARMACOGENETIC+TESTING | Search PHARMACOGENETIC+TESTING |
9 | PHARMACOGENOMICS EDUCATION | 124019 | 0% | 100% | 5 | Search PHARMACOGENOMICS+EDUCATION | Search PHARMACOGENOMICS+EDUCATION |
10 | STRATIFIED MEDICINE | 99533 | 1% | 24% | 17 | Search STRATIFIED+MEDICINE | Search STRATIFIED+MEDICINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHWARTZ, EJ , ISSA, AM , (2017) THE ROLE OF HOSPITAL PHARMACISTS IN THE ADOPTION AND USE OF PHARMACOGENOMICS AND PRECISION MEDICINE.PERSONALIZED MEDICINE. VOL. 14. ISSUE 1. P. 27 -35 | 41 | 80% | 0 |
2 | MILLS, R , HAGA, SB , (2013) CLINICAL DELIVERY OF PHARMACOGENETIC TESTING SERVICES: A PROPOSED PARTNERSHIP BETWEEN GENETIC COUNSELORS AND PHARMACISTS.PHARMACOGENOMICS. VOL. 14. ISSUE 8. P. 957-968 | 49 | 62% | 8 |
3 | DUNNENBERGER, HM , BISZEWSKI, M , BELL, GC , SEREIKA, A , MAY, H , JOHNSON, SG , HULICK, PJ , KHANDEKAR, J , (2016) IMPLEMENTATION OF A MULTIDISCIPLINARY PHARMACOGENOMICS CLINIC IN A COMMUNITY HEALTH SYSTEM.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 73. ISSUE 23. P. 1956 -1966 | 41 | 61% | 1 |
4 | RELLING, MV , EVANS, WE , (2015) PHARMACOGENOMICS IN THE CLINIC.NATURE. VOL. 526. ISSUE 7573. P. 343 -350 | 37 | 45% | 41 |
5 | WEITZEL, KW , AQUILANTE, CL , JOHNSON, S , KISOR, DF , EMPEY, PE , (2016) EDUCATIONAL STRATEGIES TO ENABLE EXPANSION OF PHARMACOGENOMICS-BASED CARE.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 73. ISSUE 23. P. 1986 -1998 | 34 | 77% | 0 |
6 | DUNNENBERGER, HM , CREWS, KR , HOFFMAN, JM , CAUDLE, KE , BROECKEL, U , HOWARD, SC , HUNKLER, RJ , KLEIN, TE , EVANS, WE , RELLING, MV , (2015) PREEMPTIVE CLINICAL PHARMACOGENETICS IMPLEMENTATION: CURRENT PROGRAMS IN FIVE US MEDICAL CENTERS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55. VOL. 55. ISSUE . P. 89 -+ | 31 | 55% | 34 |
7 | FORMEA, CM , NICHOLSON, WT , VITEK, CR , (2015) AN INTER-PROFESSIONAL APPROACH TO PERSONALIZED MEDICINE EDUCATION: ONE INSTITUTION'S EXPERIENCE.PERSONALIZED MEDICINE. VOL. 12. ISSUE 2. P. 129 -138 | 32 | 73% | 0 |
8 | GUO, YL , SHI, LM , HONG, HX , SU, ZQ , FUSCOE, J , NING, BT , (2013) STUDIES ON ABACAVIR-INDUCED HYPERSENSITIVITY REACTION: A SUCCESSFUL EXAMPLE OF TRANSLATION OF PHARMACOGENETICS TO PERSONALIZED MEDICINE.SCIENCE CHINA-LIFE SCIENCES. VOL. 56. ISSUE 2. P. 119-124 | 31 | 66% | 14 |
9 | PATEL, HN , URSAN, ID , ZUEGER, PM , CAVALLARI, LH , PICKARD, AS , (2014) STAKEHOLDER VIEWS ON PHARMACOGENOMIC TESTING.PHARMACOTHERAPY. VOL. 34. ISSUE 2. P. 151-165 | 26 | 79% | 6 |
10 | AVIDOR, B , GIRSHENGORN, S , GILADI, L , ISRAEL, S , KATZ, R , TURNER, D , (2016) VALIDATION OF TWO COMMERCIAL REAL-TIME PCR ASSAYS FOR RAPID SCREENING OF THE HLA-B*57:01 ALLELE IN THE HIV CLINICAL LABORATORY.JOURNAL OF VIROLOGICAL METHODS. VOL. 237. ISSUE . P. 18 -24 | 24 | 86% | 0 |
Classes with closest relation at Level 1 |